Christian Lood (Former)
1 – 43 of 43
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Argonaute, Vault, and Ribosomal Proteins Targeted by Autoantibodies in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
- 2022
-
Mark
N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis
(
- Contribution to journal › Article
- 2020
-
Mark
High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
The non-haemostatic role of platelets in systemic lupus erythematosus
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA
(
- Contribution to journal › Article
-
Mark
Comment on : Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus: Reply
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Endothelial dysfunction is associated with activation of the type I interferon system and platelets in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
(
- Contribution to journal › Article
-
Mark
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
(
- Contribution to journal › Article
-
Mark
Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjögren's syndrome and systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Prasugrel 5 mg inhibits platelet P-selectin and GPIIb–IIIa expression in very elderly and non elderly : results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients
(
- Contribution to journal › Article
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article
- 2015
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Temperature effects on haemostasis in whole blood from ticagrelor- and aspirin-treated patients with acute coronary syndrome.
(
- Contribution to journal › Article
- 2014
-
Mark
Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.
(
- Contribution to journal › Article
-
Mark
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Temperature effects on haemostasis in whole blood from ticagrelor- and aspirin-treated patients with acute coronary syndrome
2014) Nordiskt Koagulationsmöte(
- Contribution to conference › Poster
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2013
-
Mark
Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.
(
- Contribution to journal › Article
-
Mark
Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2012
-
Mark
On the immunopathogenesis of systemic lupus erythematosus - Immune complexes, type I interferon system, complement system and platelets
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus - a possible link to venous thrombosis?
(
- Contribution to journal › Article
-
Mark
Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
(
- Contribution to journal › Article
-
Mark
Combination of Autoantibodies Against Different Histone Proteins Influences Complement-dependent Phagocytosis of Necrotic Cell Material by Polymorphonuclear Leukocytes in Systemic Lupus Erythematosus.
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - a possible new treatment?
(
- Contribution to journal › Published meeting abstract
-
Mark
Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2010
-
Mark
Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases
(
- Contribution to journal › Article
-
Mark
The IgG specific endoglycosidase EndoS inhibits both cellular and complement mediated autoimmune hemolysis.
(
- Contribution to journal › Article
-
Mark
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
C1q Inhibits Immune Complex-Induced Interferon-alpha Production in Plasmacytoid Dendritic Cells A Novel Link Between C1q Deficiency and Systemic Lupus Erythematosus Pathogenesis
(
- Contribution to journal › Article
-
Mark
C1q inhibits immune complex induced IFN-alpha production in plasmacytoid dendritic cells-A novel link between C1q deficiency and SLE pathogenesis
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2857-2857(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Role of C1q in regulation of IFN-alpha production
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.706-706(
- Contribution to journal › Published meeting abstract